ATE460168T1 - Nicht-radioaktives strontiummittel zur behandlung von krebs - Google Patents
Nicht-radioaktives strontiummittel zur behandlung von krebsInfo
- Publication number
- ATE460168T1 ATE460168T1 AT03103850T AT03103850T ATE460168T1 AT E460168 T1 ATE460168 T1 AT E460168T1 AT 03103850 T AT03103850 T AT 03103850T AT 03103850 T AT03103850 T AT 03103850T AT E460168 T1 ATE460168 T1 AT E460168T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer
- treatment
- radioactive strontium
- agent
- strontium agent
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 title abstract 4
- 229910052712 strontium Inorganic materials 0.000 title abstract 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03103850A EP1523985B1 (de) | 2003-10-17 | 2003-10-17 | Nicht-radioaktives Strontiummittel zur Behandlung von Krebs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE460168T1 true ATE460168T1 (de) | 2010-03-15 |
Family
ID=34354592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03103850T ATE460168T1 (de) | 2003-10-17 | 2003-10-17 | Nicht-radioaktives strontiummittel zur behandlung von krebs |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20070031476A1 (de) |
| EP (1) | EP1523985B1 (de) |
| CN (1) | CN1886143B (de) |
| AT (1) | ATE460168T1 (de) |
| AU (1) | AU2004281559B2 (de) |
| DE (1) | DE60331654D1 (de) |
| DK (1) | DK1523985T3 (de) |
| ES (1) | ES2342461T3 (de) |
| NO (1) | NO20062229L (de) |
| RU (1) | RU2363479C2 (de) |
| WO (1) | WO2005037295A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI122450B (fi) * | 2007-12-28 | 2012-01-31 | Neurofood Ab Oy | Koostumus steriilin inflammaation hoitoon |
| RU2440037C2 (ru) * | 2009-10-19 | 2012-01-20 | Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" | Способ определения направленности патологического процесса при раке легкого |
| BR112013003722A2 (pt) * | 2010-08-18 | 2016-08-02 | Colgate Palmolive Co | produtos para cuidado e métodos de uso e fabricação dos mesmos |
| FI123756B (fi) * | 2010-09-21 | 2013-10-31 | Neurofood Ab Oy | Parannettu lisäravinne syövän hoitamiseksi tai ennaltaehkäisemiseksi |
| EP2530068A1 (de) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | Neue Strontiumsalze, deren Synthese und Verwendung bei der Behandlung von Osteoporose |
| WO2013013003A1 (en) * | 2011-07-21 | 2013-01-24 | Emory University | Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation |
| MX383705B (es) * | 2014-07-21 | 2025-03-14 | Oxolife Sl | Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético, así como para mejorar la eficacia de las técnicas de reproducción asistida. |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB602029A (en) * | 1942-04-17 | 1948-05-19 | Western Condensing Co | Improvements in or relating to process of manufacturing a vitamin concentrate |
| GB602209A (en) * | 1945-06-13 | 1948-05-21 | Norton Co | Hydraulic table reciprocating mechanism |
| EP0366869A3 (de) * | 1988-10-17 | 1991-06-12 | Lycon Ag | Bakteriostatische,Bakterizide und Pilzabweisende Zusammensetzung und Verwendung derselben |
| CN1082845A (zh) | 1992-12-21 | 1994-03-02 | 颜怀玮 | 营养平衡强化型矿泉水及制造方法 |
| CN1053091C (zh) * | 1993-03-13 | 2000-06-07 | 彭建汉 | 天然竹汁保健饮料 |
| CN1048405C (zh) * | 1993-04-07 | 2000-01-19 | 广西北海市华侨鸿发有限公司 | 速溶金花茶 |
| CN1113720A (zh) * | 1994-05-24 | 1995-12-27 | 云南智成科技实业公司 | 保健液及其生产方法 |
| US5650316A (en) * | 1994-06-06 | 1997-07-22 | Research Development Foundation | Uses of triplex forming oligonucleotides for the treatment of human diseases |
| EP0737471A3 (de) * | 1995-04-10 | 2000-12-06 | L'oreal | Verwendung von Erdalkalimetallsalze als TNF-alpha Inhibitor in einer topischen Zusammensetzung und die so hergestellte Zusammensetzung |
| FR2740341B1 (fr) * | 1995-10-26 | 1997-12-19 | Oreal | Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau |
| CN1153053A (zh) * | 1995-12-28 | 1997-07-02 | 汪贵昌 | 一种治疗肿瘤的克癌灵中药 |
| US5916143A (en) * | 1996-04-30 | 1999-06-29 | Apple; Marc G. | Brachytherapy catheter system |
| WO2000035930A1 (en) * | 1998-01-20 | 2000-06-22 | Parker Hughes Institute | Vanadium compounds for treating cancer |
| CA2339473A1 (en) * | 1998-08-04 | 2000-02-17 | John V. Kosbab | Nutrient and therapeutic compositions for the treatment of cancer |
| CA2382262C (en) | 1999-08-30 | 2004-12-07 | Ocean Nutrition Canada Ltd. | A nutritional supplement for lowering serum triglyceride and cholesterol levels |
| AU1848601A (en) * | 1999-12-09 | 2001-06-18 | Bio Syntech Canada Inc | Mineral-polymer hybrid composition |
| US6456680B1 (en) * | 2000-03-29 | 2002-09-24 | Tci Incorporated | Method of strontium-89 radioisotope production |
| NO20014746D0 (no) * | 2001-09-28 | 2001-09-28 | Clas M Kjoelberg | Smertelindrende middel |
| JP2005533001A (ja) * | 2002-03-04 | 2005-11-04 | メディミューン，インコーポレーテッド | インテグリンαｖβ３アンタゴニストを他の物質と併用投与する癌の予防または治療方法 |
-
2003
- 2003-10-17 ES ES03103850T patent/ES2342461T3/es not_active Expired - Lifetime
- 2003-10-17 AT AT03103850T patent/ATE460168T1/de not_active IP Right Cessation
- 2003-10-17 DE DE60331654T patent/DE60331654D1/de not_active Expired - Lifetime
- 2003-10-17 EP EP03103850A patent/EP1523985B1/de not_active Expired - Lifetime
- 2003-10-17 DK DK03103850.8T patent/DK1523985T3/da active
-
2004
- 2004-10-15 WO PCT/FI2004/000618 patent/WO2005037295A1/en not_active Ceased
- 2004-10-15 US US10/575,752 patent/US20070031476A1/en not_active Abandoned
- 2004-10-15 RU RU2006115785/15A patent/RU2363479C2/ru not_active IP Right Cessation
- 2004-10-15 CN CN2004800350230A patent/CN1886143B/zh not_active Expired - Fee Related
- 2004-10-15 AU AU2004281559A patent/AU2004281559B2/en not_active Ceased
-
2006
- 2006-05-18 NO NO20062229A patent/NO20062229L/no not_active Application Discontinuation
-
2009
- 2009-11-30 US US12/626,980 patent/US8703211B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60331654D1 (de) | 2010-04-22 |
| WO2005037295A1 (en) | 2005-04-28 |
| RU2006115785A (ru) | 2007-11-27 |
| NO20062229L (no) | 2006-05-18 |
| EP1523985B1 (de) | 2010-03-10 |
| US20070031476A1 (en) | 2007-02-08 |
| ES2342461T3 (es) | 2010-07-07 |
| US20100074968A1 (en) | 2010-03-25 |
| AU2004281559A1 (en) | 2005-04-28 |
| US8703211B2 (en) | 2014-04-22 |
| DK1523985T3 (da) | 2010-05-31 |
| EP1523985A1 (de) | 2005-04-20 |
| CN1886143A (zh) | 2006-12-27 |
| AU2004281559B2 (en) | 2010-04-01 |
| RU2363479C2 (ru) | 2009-08-10 |
| CN1886143B (zh) | 2011-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1626730A4 (de) | Verfahren, gerät und zusammensetzung zur behandlung von akne | |
| ATE430555T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von asthma | |
| DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
| DE60204322D1 (de) | Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen | |
| DE602004022036D1 (de) | Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen | |
| ATE396174T1 (de) | Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| PL1654253T3 (pl) | Podstawione pochodne 3-pirolidynoindolu | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| DE60034871D1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| DE60136826D1 (de) | Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs | |
| DK1560812T3 (da) | Aminocyclohexyletherforbindelser og anvendelser deraf | |
| DE60229959D1 (de) | Kombinationstherapie zur behandlung von krebs | |
| DE602005023877D1 (de) | Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide | |
| UA88645C2 (ru) | Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей | |
| DE60204584D1 (de) | Zusammensetzungen enthaltend eine niedrige konzentration an peroxide zur behandlung von vaginitis | |
| DE602004023100D1 (de) | Verbindungen und verfahren zur behandlung von dyslipidemie | |
| DE60331654D1 (de) | Nicht-radioaktives Strontiummittel zur Behandlung von Krebs | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
| EP1253930A4 (de) | Methoden und zusammensetzungen zur behandlung hepatozellulären krebses | |
| ATE545421T1 (de) | Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat | |
| DE60334289D1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
| BRPI0409768A (pt) | composto, uso de composto, composição farmacêutica, método para tratar e/ou prevenir cáncer, e, processo para preparar o composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |